Lyell Immunopharma Inc. (LYEL)
NASDAQ: LYEL
· Real-Time Price · USD
13.00
-0.30 (-2.26%)
At close: Sep 12, 2025, 1:57 PM
Lyell Immunopharma Revenue
Lyell Immunopharma reported an annual revenue of $61K, reflecting a -53.08% growth. For the quarter ending June 30, 2025, Lyell Immunopharma generated $8K in revenue.
Revenue (ttm)
61K
Revenue Growth
-53.08%
Price / Sales Ratio
54867.93
Revenue / Employee
203.33
Employees
300
Market Cap
249.75M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 61K | -53.08% |
| Dec 31, 2023 | 130K | -99.85% |
| Dec 31, 2022 | 84.68M | +695.15% |
| Dec 31, 2021 | 10.65M | +37.31% |
| Dec 31, 2020 | 7.76M | +1080.52% |
| Dec 31, 2019 | 657K | n/a |